ALERT: Grabar Law Office Investigates Claims on Behalf of Shareholders of Paragon 28, Inc. (FNA)
Philadelphia, Pennsylvania--(Newsfile Corp. - November 8, 2024) - Grabar Law Office is actively investigating claims on behalf of shareholders of Paragon 28, Inc. (NYSE: FNA), a company that "develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace." For additional details, visit https://grabarlaw.com/the-latest/paragon28-shareholder-investigation/.
Why?
A federal securities class action was recently filed against Paragon 28 and three of its officers. The complaint alleges that from May 5, 2023, to August 8, 2024, Paragon 28, through certain officers and directors, made false and/or misleading statements and failed to disclose that: (1) Paragon 28's financial statements were misstated; (2) the company lacked adequate internal controls, with critical issues understated; and (3) as a result, Defendants' statements about its business, operations, and prospects were materially false and misleading or lacked a reasonable basis during the period.
What Now?
Shareholders who purchased Paragon 28 shares between May 5, 2023, and August 8, 2024, as well as long-term shareholders who acquired shares prior to May 5, 2023, are encouraged to review their legal rights and options. For more information, please visit the landing page at https://grabarlaw.com/the-latest/paragon28-shareholder-investigation/. You can also contact Joshua H. Grabar at jgrabar@grabarlaw.com or Mia R. Heller at mheller@grabarlaw.com directly, or call 267-507-6085 for further assistance.
Grabar Law Office is committed to ensuring shareholder rights are protected.
Attorney Advertising Disclaimer
$FNA #Paragon28
Contact:
Joshua H. Grabar, Esq.
Grabar Law Office
One Liberty Place
1650 Market Street, Suite 3600
Philadelphia, PA 19103
Tel: 267-507-6085
Email: jgrabar@grabarlaw.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/229380
The Paragon 28 Stock at the time of publication of the news with a raise of +1,53 % to 6,65USD on Lang & Schwarz stock exchange (08. November 2024, 21:51 Uhr).